A detailed history of Citigroup Inc transactions in Cronos Group Inc. stock. As of the latest transaction made, Citigroup Inc holds 4 shares of CRON stock, worth $9. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4
Previous 4 -0.0%
Holding current value
$9
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

SELL
$1.72 - $2.19 $646 - $823
-376 Reduced 98.95%
4 $0
Q3 2023

Nov 09, 2023

BUY
$1.68 - $2.47 $638 - $938
380 New
380 $0
Q2 2022

Aug 10, 2022

SELL
$2.59 - $3.92 $5,410 - $8,188
-2,089 Reduced 72.51%
792 $2,000
Q1 2022

May 12, 2022

BUY
$3.0 - $4.25 $8,643 - $12,244
2,881 New
2,881 $11,000

Others Institutions Holding CRON

About Cronos Group Inc.


  • Ticker CRON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 377,896,000
  • Market Cap $858M
  • Description
  • Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of...
More about CRON
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.